TRAVERE THERAPEUTICS, INC.
TRAVERE THERAPEUTICS, INC. is a Public Limited Company registered in United States under 3617121, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 31 October 2013 and lists its registered address as United States. 5 shareholders are on record for TRAVERE THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for TRAVERE THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 9.1% — the largest recorded stake — followed by Delaware Group Equity Funds V-Nomura Small Cap Core Fund at 4.5%; the remaining 3 shareholders shown hold smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 9.1% | California Secretary of State — bizfile Online | |
| Delaware Group Equity Funds V-Nomura Small Cap Core Fund | 4.5% | California Secretary of State — bizfile Online | |
| iShares Trust-iShares Russell 2000 ETF | 3.2% | California Secretary of State — bizfile Online | |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 1.3% | California Secretary of State — bizfile Online | |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.3% | California Secretary of State — bizfile Online |
Officers
5
The President, Ceo & Director of TRAVERE THERAPEUTICS, INC. currently on record is Eric M. Dube Ph.d.; five officers are currently on record for TRAVERE THERAPEUTICS, INC., filed with California Secretary of State — bizfile Online.
The register reports 16 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at TRAVERE THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
TRAVERE THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 6 subsidiaries recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 6 subsidiaries span United States, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 6 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
TRAVERE THERAPEUTICS, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns TRAVERE THERAPEUTICS, INC.?
Five shareholders are currently on record for TRAVERE THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 9.1% — the largest recorded stake — followed by Delaware Group Equity Funds V-Nomura Small Cap Core Fund at 4.5%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is TRAVERE THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for TRAVERE THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does TRAVERE THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for TRAVERE THERAPEUTICS, INC..
What is TRAVERE THERAPEUTICS, INC.'s company registration number?
TRAVERE THERAPEUTICS, INC.'s registration number is 3617121, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is TRAVERE THERAPEUTICS, INC. still an active company?
TRAVERE THERAPEUTICS, INC.'s status on California Secretary of State — bizfile Online is listed as active.
When was TRAVERE THERAPEUTICS, INC. incorporated?
TRAVERE THERAPEUTICS, INC. was incorporated on 31 October 2013, according to California Secretary of State — bizfile Online.
What is TRAVERE THERAPEUTICS, INC.'s registered address?
The registered address on file for TRAVERE THERAPEUTICS, INC. is United States.
What legal structure is TRAVERE THERAPEUTICS, INC. registered as?
TRAVERE THERAPEUTICS, INC. is registered as a Public Limited Company in United States.
Who are the officers/directors of TRAVERE THERAPEUTICS, INC.?
The President, Ceo & Director of TRAVERE THERAPEUTICS, INC. currently on record is Eric M. Dube Ph.d.; five officers are currently on record for TRAVERE THERAPEUTICS, INC., filed with California Secretary of State — bizfile Online. Management authority at TRAVERE THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does TRAVERE THERAPEUTICS, INC. have a parent company or subsidiaries?
TRAVERE THERAPEUTICS, INC. has no recorded parent company — it sits at the top of its own group structure, with 6 subsidiaries recorded beneath it across 2 jurisdictions. Those 6 subsidiaries span United States, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. Two of the 6 go a level deeper still, with their own further subsidiaries recorded beneath them — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to TRAVERE THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to TRAVERE THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access TRAVERE THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like TRAVERE THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 4 October 2026.